Seminars by Professor Christophe P. Nicot, Editor-in-Chief for Molecular Cancer and Professor in the Department of Pathology & Laboratory Medicine at the University of Kansas Medical Center
You are welcome to attend the seminars. Please find the details below:
Speaker:
Professor Christophe P. Nicot
Editor-in-Chief for Molecular Cancer
Professor, Department of Pathology & Laboratory Medicine
University of Kansas Medical Center
About the Speaker:
Christophe P. Nicot is a Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center. Nicot received his PhD from the University of Bordeaux in France in 1995. His research focuses on the oncogenic Human T-cell Lymphotropic Virus type I (HTLV-I), the etiological agent of an aggressive and fatal leukemia known as Adult T-cell Leukemia/Lymphoma (ATLL) disease. Nicot’s laboratory studies early and late molecular events associated with cellular transformation and leukemogenesis. They are especially interested in genome instability, telomerase reactivation, RNA export and signaling pathways involved in T-cell transformation and virus replication. They also study new therapeutic approaches for the treatment of ATLL. Prof Nicot is the Editor-in-Chief of the journal Molecular Cancer and serves as an editorial member and reviewer of several internationally reputed journals. He is a member of many international affiliations with administrative responsibilities. Nicot has authored more than a hundred research articles.
Seminar 1 “Molecular Cancer: An Inside Glimpse With the Editor in Chief”
This presentation will discuss how to build a successful scientific journal with high impact factor, how does Molecular Cancer operate and how to best prepare manuscripts to enhance chances to get published.
Date: 22 Jan, 2024 (Mon)
Time: 11:00am to 1:00pm (Registration starts at 10:30am)
Venue: Lecture Theatre 2, 1/F, HKUMed Academic Building, 3 Sassoon Road, Pokfulam, Hong Kong
Fee: Free of Charge
Registration: Please click here
Moderator:
Professor Yibin Feng
Director, School of Chinese Medicine, HKU
Seminar 2 “Role of FBXW7 Tumor Suppressor in Human T Cell Leukemia”
This presentation will discuss the role of FBXW7 in cancer development with a special emphasis to lymphoproliferative diseases such as T cell leukemias.
Date: 24 Jan, 2024 (Wed)
Time: 2:15pm – 4:15pm (Registration starts at 1:45pm)
Venue: Lecture Theatre 1, 1/F, HKUMed Academic Building, 3 Sassoon Road, Pokfulam, Hong Kong
Fee: Free of Charge
Registration: Please click here
Moderator:
Dr Ning Wang
Assistant Professor, School of Chinese Medicine, HKU
Enquires:
Tel: 81000538
